mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-05 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-05 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0001 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0001 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0003 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0003 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |